A Novel Approach to Therapeutic Delivery Across the Blood-Brain Barrier

Aliada Therapeutics’ chief scientific officer, John Dunlop, PhD, discusses the MODEL™ platform.

Leave a Reply

Your email address will not be published. Required fields are marked *